세계의 프리미엄 백내장 수술(PCS) 시장에 대해 조사했으며, 시장 개요와 세계의 백내장 수술과 제품 매출의 분석, 중요 동향, 향후 성공을 향한 주요 요인의 분석 및 상위 13개국의 시장 동향을 제공하고 있습니다.
The new "2024 Premium Cataract Surgery Market Report" now features a five-year history of PC-IOLs, toric IOLs, and FLACS for each of the top 13 premium cataract surgery country markets in the world. For each of these countries, the report also analyzes the recent economy and projects its impact on the elderly populations that account for most premium procedures.
The report also explores the long list of recently launched new products that are destined to impact the premium cataract market-including the Carl Zeiss Micor 700 cataract handpiece, which has the potential to drive adoption of office-based cataract surgery; the Rayner Galaxy spiral trifocal IOL and many other new PC-IOLs; and the Lensar Ally, which is expected to drive growth in FLACS procedures.
The new report also examines and explains the dramatic drop in premium procedures in South Korea and outlines the potential recovery of that market over the next five years.
The "2024 Premium Cataract Surgery Market Report" is designed to provide insights into the most important premium cataract surgery (PCS) markets in the world. We've selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2024 PCS manufacturer revenue, they are: the United States, China, Japan, France, Germany, Brazil, Canada, India, Spain, South Korea, Australia, the UK, and Italy.
For each of these countries, the report focuses on specific characteristics considered vital to the understanding of the opportunities for companies planning to market premium cataract surgery devices or looking to assess the value of each market.
The report offers an in-depth examination of the 2024 premium cataract surgery (PCS) market. It includes analysis of the global PCS procedure and product revenue, identification of important trends, and discussion of key factors for future success. The following information is also included: